Advanced search
Publication Cover
Clinical Epidemiology Volume 16, 2024 - Issue
Submit an article Journal homepage
88
Views
0
CrossRef citations to date
0
Altmetric
RESPONSE TO LETTER

The Epidemiology of Bile Acid Diarrhea in Denmark [Response to Letter]

Martin L Kårhus1 Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, DenmarkORCID Iconhttps://orcid.org/0000-0002-3842-1287
ORCID Icon,
Anne-Marie Ellegaard1 Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, DenmarkCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-4389-3908
ORCID Icon,
Filip K Knop1 Center for Clinical Metabolic Research, Copenhagen University Hospital – Herlev and Gentofte, Hellerup, Denmark;2 Steno Diabetes Center Copenhagen, Herlev, Denmark;3 Department of Clinical Medicine, Faculty of Health and Medical Science, University of Copenhagen, Copenhagen, DenmarkORCID Iconhttps://orcid.org/0000-0002-2495-5034
ORCID Icon &
Line L Kårhus4 Center for Clinical Research and Prevention, Copenhagen University Hospital – Bispebjerg and Frederiksberg, Frederiksberg, DenmarkORCID Iconhttps://orcid.org/0000-0002-1722-8269
ORCID Icon
Pages 7-8 | Received 15 Dec 2023, Accepted 03 Jan 2024, Published online: 16 Jan 2024

References

  • Kårhus ML, Ellegaard AM, Winther-Jensen M, Hansen S, Knop FK, Kårhus LL. The epidemiology of bile acid diarrhea in Denmark. Clin Epidemiol. 2023;15:1173–1181. doi:10.2147/clep.S442054
  • Henriksen DP, Rasmussen L, Hansen MR, Hallas J, Pottegård A. Comparison of the five Danish regions regarding demographic characteristics, healthcare utilization, and medication use--a descriptive cross-sectional study. PLoS One. 2015;10(10):e0140197. doi:10.1371/journal.pone.0140197
  • Andrae DA, Patrick DL, Drossman DA, Covington PS. Evaluation of the Irritable Bowel Syndrome Quality of Life (IBS-QOL) questionnaire in diarrheal-predominant irritable bowel syndrome patients. Health Qual Life Outcomes. 2013;11:208. doi:10.1186/1477-7525-11-208
  • Paré P, Gray J, Lam S, et al. Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome: baseline results from LOGIC (Longitudinal Outcomes Study of Gastrointestinal Symptoms in Canada), a naturalistic study. Clin Ther. 2006;28:1726–1735. doi:10.1016/j.clinthera.2006.10.010
  • Kårhus ML, Brønden A, Forman JL, et al. Safety and efficacy of liraglutide versus colesevelam for the treatment of bile acid diarrhoea: a randomised, double-blind, active-comparator, non-inferiority clinical trial. Lancet Gastroenterol Hepatol. 2022;7(10):922–931. doi:10.1016/S2468-1253(22)00198-4
  • Rahbek MT, Lund LC, Hallas J. A case for screening real-world data for collateral drug benefits: glucagon-like peptide 1 receptor agonists and bile acid diarrhea. Pharmacoepidemiol Drug Saf. 2023. doi:10.1002/pds.5673
  • Conley TE, White KL, Bond A, Harrison S, McLaughlin J, Lal S. Emerging uses of glucagon-like peptide 1 (GLP-1) receptor agonists following ileal resection: literature review and case examples. Front Gastroenterol. 2023;14(6):521–526. doi:10.1136/flgastro-2023-102402
  • Kårhus ML, Brønden A, Røder ME, Leotta S, Sonne DP, Knop FK. Remission of bile acid malabsorption symptoms following treatment with the glucagon-like peptide 1 receptor agonist liraglutide. Gastroenterology. 2019;157(2):569–571. doi:10.1053/j.gastro.2019.04.002
  • Kårhus ML, Knudsen E, Knop FK. Different effects of once-weekly and once-daily administered GLP-1RA semaglutide and liraglutide on bile acid diarrhea. J Clin Endocrinol Metab. 2022;1(1):luac004. doi:10.1210/jcemcr/luac004

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.